Related Experiment Video
Updated: May 13, 2026
08:22
Co-Culture of Murine Small Intestine Epithelial Organoids with Innate Lymphoid Cells
Published on: March 23, 2022
Innate immunity modulation by the IL-33/ST2 system in intestinal mucosa
Marina García-Miguel1, M Julieta González, Rodrigo Quera
1Disciplinary Program of Immunology, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago, Chile.
Biomed Research International
|March 14, 2013
Summary
The IL-33/ST2 system is crucial for innate immunity in the gut lining. Imbalances in this system are linked to inflammatory bowel diseases (IBD), particularly ulcerative colitis (UC).
Area of Science:
- Immunology
- Gastroenterology
- Molecular Biology
Background:
- Innate immunity protects the body from pathogens, especially in high-contact areas like the gut and skin.
- The gastrointestinal tract relies on commensal bacteria for digestion and antigen tolerance.
- Immune system dysfunction can lead to intestinal inflammation and chronic diseases like inflammatory bowel diseases (IBD).
Purpose of the Study:
- To review the role of the IL-33/ST2 system in the innate immune response of the intestinal mucosa.
- To explore the significance of the IL-33/ST2 axis in inflammatory bowel diseases (IBD), with a focus on ulcerative colitis (UC).
Main Methods:
- Literature review of studies on innate immunity, the IL-33/ST2 system, and IBD.
- Analysis of the involvement of IL-33/ST2 in intestinal mucosal immunity.
- Examination of the association between IL-33/ST2 imbalance and ulcerative colitis pathogenesis.
Main Results:
- The IL-33/ST2 axis is a key modulator of innate immunity in the intestinal mucosa.
- An imbalance in the IL-33/ST2 system is observed in the intestinal mucosa of ulcerative colitis patients.
- This imbalance is implicated in the inflammatory processes underlying IBD, especially UC.
Conclusions:
- The IL-33/ST2 system plays a critical role in maintaining intestinal mucosal immunity.
- Dysregulation of the IL-33/ST2 axis contributes to the development and progression of ulcerative colitis.
- Targeting the IL-33/ST2 pathway may offer therapeutic strategies for IBD.
Related Concept Videos
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
01:23Renewal of Intestinal Stem Cells
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.